You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 59 No. 6, June 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on ISI (11)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Dementias
 •Neurogenetics
 •Movement Disorders
 •Parkinson Disease/ Parkinsonian Disorders
 •Genetic Disorders
 •Alert me on articles by topic

Clinical Features and Disease Haplotypes of Individuals With the N279K tau Gene Mutation

A Comparison of the Pallidopontonigral Degeneration Kindred and a French Family

Yoshio Tsuboi, MD; Ryan J. Uitti, MD; Marie-Bernadette Delisle, MD; Joaquim J. Ferreira, MD; Christine Brefel-Courbon, MD; Olivier Rascol, MD, PhD; Bernardino Ghetti, MD; Jill R. Murrell, MD; Michael Hutton, PhD; Matthew Baker, BSc; Zbigniew K. Wszolek, MD

Arch Neurol. 2002;59:943-950.

Background  An N279K missense mutation in exon 10 of the tau gene reported in an American family with pallidopontonigral degeneration (PPND family) was recently found in members of a French kindred with dementia and supranuclear palsy.

Objectives  To compare clinical phenotypes of both families and to perform genealogical and molecular genetic studies to determine whether they are derived from a common founder.

Design and Methods  We performed clinical examinations of affected members of both families and compared clinical phenotypes, existing genealogical family records, and chromosome 17 microsatellite repeat markers in the vicinity of the tau gene.

Results  The inheritance pattern is autosomal dominant in the PPND family and appears so in the French family. Average age at onset of clinical symptoms was 43 years in the PPND family and 41 years in the French family. Mean disease duration was 8 years in the PPND family and 6 years in the French family. Parkinsonism, personality changes, and dementia of the frontotemporal type were seen in both kindreds. All affected patients exhibited rapidly progressive parkinsonism characterized by bradykinesia, tremor, postural instability, and rigidity. Some had a transient response to levodopa therapy during the initial stages. Pyramidal signs and eye movement abnormalities, including supranuclear gaze palsy, were common. Results of linkage studies of the tau region in chromosome 17 did not reveal a haplotype common to both kindreds.

Conclusions  Affected members from both families had more clinical similarities than differences. Results of genealogical and molecular genetic studies determined that the families were not related. The N279K mutations found in both families have independent origins.


From the Departments of Neurology (Drs Tsuboi, Uitti, and Wszolek) and Research (Dr Hutton and Mr Baker), Mayo Clinic, Jacksonville, Fla; Service d'Anatomie et de Cytologie Pathologiques and Institut National de la Santé et de la Récherche Médicale U466, Centre Hospitalier Universitaire Rangueil (Dr Delisle), and the Clinical Investigation Centre and Neuropharmacology Unit, Centre Hospitalier Universitaire Purpan (Drs Ferreira, Brefel-Courbon, and Rascol), Toulouse, France; and the Department of Pathology, Indiana University School of Medicine, Indianapolis (Drs Ghetti and Murrell).


RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2002;59(6):1048-1050.
FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.